Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Share-based Compensation (2025 - 2026)

Updated

Impact Biomedical's Share-based Compensation was $1.44 million in Q1 2026, compared with $29,000 a year earlier.

Analysis

Impact Biomedical (IBO) Share-based Compensation (2025 - 2026) Analysis & Trends

For FY2025, Share-based Compensation at Impact Biomedical came in at $190,000, up 900.0% from FY2024.

  • In earlier years, Share-based Compensation was $19,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.44 Mn
Jun 30, 2025 161,000.00
Mar 31, 2025 29,000.00
API Access

Impact Biomedical Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBO&period=max&api_key=YOUR_API_KEY